INTRODUCTION
14, 44) , little is known about immunological mechanisms involved in intracerebral xenotransplantation. Naturally occurring xenoreactive antibodies and com-A transplantation therapy using human fetal dopaminergic cells to substitute the shortage of dopamine in plement play an important role in the rejection of transplanted vascularized solid organs by initiating hyper-the striatum of patients suffering from Parkinson's disease has been the subject of both experimental and clini-acute rejection (1,37); in a later stage, these factors may play a central role in delayed xenograft rejection (2, 38) . cal investigation (6, 17, 26, 35, 36, 42, 50) . Xenotransplantation using porcine fetal ventral mesencephalic (pfVM)
Although hyperacute rejection of porcine cell suspension grafts after transplantation is unlikely, in vivo stud-tissue is considered a viable alternative that addresses shortage of human fetal tissue as well as a number of ies have shown that there is an important role for antibodies and complement in the rejection of such intracerebral practical and ethical issues involved in the use of human fetal tissue (18, 20, 21, 33) . Although clinical trials using xenografts (4, 5, 24, 28, 29, 48) . Studies concerning the transplantation of vascularized organs or pancreatic islets be-pfVM as a donor source have already taken place (10, yond species borders have shown that if hyperacute re-Trypsin Medium. The trypsin medium used was Ca 2+ and Mg 2+ -free Hanks's buffer, 0.6% glucose, 100 U/100 jection has been overcome, mechanisms involving the cellular compartment of the immune system are still ca-mg per ml penicillin/streptomycin, 0.3 mM/ml HEPES, 500 mg/ml DNAse, and 0.1% Worthington's trypsin. pable of destroying the graft (9, 23, 27, 43, 51) . The question is whether these findings can be extrapolated to Trypsin Inhibiting Medium. The trypsin inhibiting transplantation of fetal xenogeneic brain cells into a supmedium used was Ca 2+ and Mg 2+ -free Hank's buffer soposedly immunoprivileged organ such as the brain. In lution, 500 mg/ml DNAse, 100 U/100 mg per ml penivitro there is evidence of human T-cell reactivity (7) and cillin/streptomycin, 20% fetal calf serum (FCS), and 100 human NK reactivity (47) against pf brain cells. Also, mg/ml soybean trypsin inhibitor. a role for host T cells in the rejection of intracerebral Washing Medium. The washing medium used was xenografts can be deducted from the beneficial effect of Ca 2+ and Mg 2+ -free Hank's buffer solution, 500 mg/ml cyclosporin A (8) or blocking of swine leucocyte anti-DNAse, 0.6% glucose, 100 U/100 mg per ml penicillin/ gen (SLA) class I (11, 34) on the survival of such a graft streptomycin, 0.3 mM/ml HEPES with 10% or 20% FCS. in a xenogeneic animal model. Other in vivo studies pro-Cryopreservation Medium. The cryopreservation mevide further evidence of cellular mechanisms playing an dium used was 0.9% saline, 0.6% glucose, and 10% diimportant role in the rejection of intracerebral xenotransmethyl sulfoxide (DMSO) (AIM-V medium, Gibco). plantation (13, 39) .
With respect to this cell-mediated xenoreactivity, hu-Preparation of pfVM and Porcine Spleen Cells man lymphocytes may have the capacity to directly recognize and lyse pfVM cells through direct activity of Fetuses from 28 day pregnant cross-bred Dutch Yorkshire Landrace pigs were obtained by hysterotomy NK cells, or antibody-dependent NK cell activity (ADCC), as previously reported (47). Alternatively, xenograft and the VM was microscopically isolated and cut in 6-8 pieces (19, 31, 49) . Half of the tissue fragments were cells could activate or "prime" human T cells. Priming human lymphocytes for xenospecific cytolytic activity stored in 0.9% saline at 4°C for 2 h before being processed into a single cell suspension; the other half was is most effectively mediated by "professional" antigen presenting cells (APC), such as macrophages or den-stored in a hibernation medium at 4°C for 44 h before being cryopreserved (25). dritic cells. pfVM explants have been shown to contain APC, which may lead to priming of human T cells as A single cell suspension was made incubating VM tissue fragments in a trypsin medium for 15 min at 37°C was shown with macrophages that were selected by in vitro culturing and were capable of inducing human T-and subsequent incubation in a trypsin inhibiting medium for 5 min at room temperature. Subsequently, the cell proliferation (7) . These data raise the question if freshly isolated pfVM cells themselves are capable of tissue was rinsed three times using a 10% FCS-containing washing medium and gently dissociated using fire-priming human lymphocytes of different individuals for xenospecific cytolytic activity and to what degree pfVM polished constricted Pasteur's pipettes with decreasing bore diameters. The number of viable cells was deter-cells are susceptible to cytolytic activity by human T cells that were primed by "professional" xenogeneic mined by the trypan blue dye exclusion test, and viability was expressed as percentage of viable cells with re-APC, such as spleen cells.
In this study we investigated direct in vitro reactivity spect to the total number of cells. Viability in this study was used as quality control only; cell suspensions with of human peripheral blood mononuclear cells (PBMC) of different donors against VM cells of E28 pig fetuses.
viability lower than 90% were not used. For cryopreservation, the hibernated tissue fragments Furthermore, we analyzed whether priming of human PBMC with pfVM induces xenospecific cytolytic activ-were transferred to a 1-ml cryotube containing 1 ml of cryopreservation medium and stored on melting ice be-ity and whether xenogeneic APC can enhance the ability of PBMC to kill pfVM cells.
fore being frozen in a programmed freezer using a freezing program described previously (25,41) and stored in MATERIALS AND METHODS liquid nitrogen (−196°C) afterwards. To thaw the frozen Reagents tissue fragments, the cryotube was placed in 37°C water for 2 min. Subsequently the supernatant was slowly di-Hibernation Medium. The hibernation medium used was 2.236 g/l KCl, 0.48 g/L MgCl 2 × 6H 2 O, 0.9 g/L glu-luted with washing medium containing 20% FCS before replacing the supernatant with washing medium to wash cose, 0.89 g/L Na 2 HPO 4 × 2H 2 O, 1.511 g/L NaH 2 PO 4 × H 2 O, 6 ml/L lactic acid (30%, Sigma). The pH was set out DMSO before processing into a single cell suspension (25). at 7.2 by adding KOH, and osmolarity was adjusted to 300 mM by adding sorbitol (22) .
Porcine spleen was obtained from the same sow do-nating the fetuses to guarantee at least semi-identity in Statistics MHC make up between spleen cells and pfVM. After Statistical analyses were performed using GraphPad mechanical dissociation of pieces of porcine spleen tis-Prism version 3.00 for Windows (GraphPad Software, sue, lymphocytes were derived using Lymfoprep (Axis-San Diego, CA, USA). To assess differences, the Wilco-Shield PoC As) gradient centrifugation. Cells were eixon matched pairs test was performed. ther used fresh or after cryopreservation using a standard RESULTS lymphocyte freezing program in a programmable freezer pfVM Cells Are Lysed by Primed Human T Cells and storing in liquid nitrogen until further use.
Human PMBC primed with porcine spleen cells Isolation and Preparation of Human Serum showed a significant xenoreactive response against porand Peripheral Blood Mononuclear Cells (PBMC) cine VM cells in half of the individuals tested ( Fig. 1B) .
In contrast, cells primed by pfVM cells did not show a Human PBMC from healthy volunteers were obtained xenospecific response to pfVM ( Fig. 1A) . Differences by Ficoll-Hyperque (Nycomed) gradient centrifugation.
were significant comparing human PMBC primed using Human serum was obtained from healthy donors and PSC with human PMBC primed with pfVM or medium heat inactivated before use.
control in their ability to lyse pfVM at an E:T ratio of To prime PBMC, fresh cells were incubated (1:1) 100:1 (p = 0.0117), 50:1 (p = 0.0117), and 12.5:1 (p = with 30 Gy irradiated pfVM cells or porcine spleen cells 0.0039) (Wilcoxon matched pairs test). as APC in serum-free AIM-V medium to which 15 U/ All donors lysed porcine spleen cells when primed by ml IL-2 was added (37°C, 5% CO 2 ). After 1 week cells xenogeneic APC (spleen cells) ( Fig. 1D ), but not after were harvested and used in a cytotoxicity assay.
priming by pfVM cells (Fig. 1C) . Differences were sig-Determination of Cytotoxicity nificant comparing human PMBC primed using PSC with human PMBC primed with pfVM or medium con-For measurement of PBMC activation and subsetrol in their ability to lyse porcine spleen cells for all E: quent lysis of pfVM and porcine spleen cells we fol-T ratios (p = 0.0039, Wilcoxon matched pairs test). lowed the protocol described by Yi et al. (51) . PBMC Although PMBC primed by xenogeneic APC lysed from nine individuals, either stimulated with adult por-pfVM, porcine spleen cells were lysed more efficiently, cine spleen cells, pfVM cells, or medium were incubated indicating that pfVM are poorly recognized (p = 0.0039 at 37°C with thawed porcine spleen cells or thawed for all E:T ratios, Wilcoxon matched pairs test). pfVM cells that were labeled with 51 Cr (200 µCi). After
Loading of pfVM and spleen cells with 51 Cr was 4 h, 51 Cr release was measured using a Packard gamma comparable as demonstrated by comparable 51 Cr release counter.
after addition of Triton 1% and background release. In-To determine direct NK cell-mediated cytotoxicity, terestingly, large differences were observed in the defreshly isolated human PBMC from six individuals were gree of xenospecific lysis between PBMC of the differincubated at 37°C with 51 Cr (200 µCi) labeled fresh ent individuals tested (Fig. 1B, D) . pfVM cells for 4 h with or without IL-2, before 51 Cr release was measured using a Packard gamma counter.
No NK Cell-Mediated Cytotoxicity or ADCC to pfVM To determine ADCC, fresh pfVM cells were labeled Human PBMC from six different individuals were with 51 Cr (200 µCi) and subsequently incubated at 37°C tested for NK reactivity against pfVM cells with and for 30 min with heat-inactivated human serum. Serum without IL-2 as additive to the medium. No NK cellwas obtained from two donors that were known to posmediated cytotoxicity could be determined in any of six sess high levels of antibodies directed against pfVM.
individuals tested, neither with nor without addition of After rinsing three times with AIM-V medium and 2% IL-2 ( Fig. 2; data not shown for testing without IL-2). human serum albumin, cells were incubated at 37°C
In addition to direct NK cell activity, ADCC was aswith PBMC from six human donors for 4 h. Subsequently, sayed using serum from two individuals with high levels 51 Cr release was measured using a Packard gamma of pfVM-specific antibodies and PBMC from six indicounter.
viduals. No ADCC reactivity could be determined (Fig. In all experiments Triton-X100 was added to deter-3). Although cytotoxicity levels seemed to decrease with mine maximum release and AIM-V medium to detera lower E:T ratio, percentages of specific lysis were very mine background release. The percentage specific lysis low and should be considered negative. was calculated as the measured minus background re-DISCUSSION lease divided by the difference between maximum and background. All measurements were performed in trip-In this study we show that porcine VM cells can be targets for cytolytic activity by human xenoreactive T lets. Data are expressed as mean values. All measurements were performed in triplets and expressed as mean values. Intra-assay variability between triplets expressed as standard deviation of the mean ranged from 0 to maximum 6.3% SD but was typically in the range of 1-2% SD.
cells, but only after they have been primed by xenoge-
In the experiments we describe in this article, T-cell activation is only possible via a direct route where donor neic APC. Without priming, human PBMC do not appear to show cytolytic activity towards xenogeneic pfVM APC activate human T cells. Cells that could function as APC after intracerebral xenotransplantation and directly cells.
Both direct and indirect routes have been described activate host T cells are microglia, macrophages, and possibly also astrocytes. Indeed, Brevig et al. have in which T cells can react with tissue antigens. After xenotransplantation, xenoantigens have been found in shown that macrophages isolated from pfVM and cultured in vitro upregulate MHC and are able to stimulate cervical lymph nodes of the recipient, suggesting indirect antigen presentation (32) . Also there is in vivo evi-T cells, as do isolated astrocytes, although not as efficiently as do macrophages (7) . However, in our experi-dence for a possible antigen presenting role of host microglia (15,16). Such an indirect route of T-cell activation ments pfVM appears to be a poor source of APC, because pfVM cells were not able to prime human PBMC may well be very important in intracerebral pfVM transplantation, because over 90% of the transplanted pfVM during in vitro coculture for a week. Furthermore, Duan et al. have shown in an in vivo allogeneic transplant cells die within the first weeks of transplantation (3, 46, 52) . These dying pfVM cells could provide a substantial model that cotransplantation of spleen cells caused rejection of a neural graft (12) . The above findings show antigenic load to host APC. Although transplanted pfVM cells appear to die predominantly from apoptosis that stimulation of allogeneic and xenogeneic immune responses is promoted by the presence of "professional" (30) , and apoptotic cell clearance usually does not trigger an immune response (40), Shrestha et al. have shown donor APC (expressing SLA class I and II). These data also support our findings that a pfVM cell suspension that apoptotic cells can evoke both humoral and cellular responses after transplantation (45) .
(with a low content of APC that could be considered with respect to individual cytotoxicity of human T cells to pfVM and PSC may well reflect significant variations in interindividual xenogeneic response patterns, possibly genetically determined. Although speculative, these findings could have significance for the clinical application of xenotransplantation in Parkinson's disease in terms of patient selection and graft survival.
In our experiments we did not see any direct human NK reactivity against pfVM cells in vitro, when testing PBMC from different donors. Also, with IL-2-stimulated human PBMC as effector cells no lysis was observed. These findings seem to be in contrast with obser- the IL-2 treatment differed significantly between Sumitran's and our experiments. Moreover, Sumitran et al used a preparation of isolated human NK cells. This probably also explains why they were able to measure professional APC) is a rather poor stimulator of a xenoup to 60% lysis at an E/T ratio of 30:1, whereas in our specific T-cell response. This is in contrast to porcine experiments no direct cytotoxicity was found, even at an spleen cells, which were able to stimulate T cells from E/T ratio of 100:1, at which it is likely that a fair amount different human donors quite effectively. Once stimuof NK cells must have been present. Nevertheless, this lated by porcine spleen cells, human T cells do recogfinding again stresses that without additional priming, nize and lyse pfVM cells. Interestingly, marked differexisting reactivity among human PBMC against xenogeences were observed between cytotoxicity of stimulated neic pfVM cells is extremely low. T cells from different human donors to both pfVM and As with direct NK reactivity, we also did not observe porcine spleen cells. Because pfVM and PSC cells were any cytotoxicity in the presence of heat-inactivated huisolated from non-inbred pigs, we used the sow that doman serum. This finding seems to indicate that human nated the fetuses as a source of spleen cells and used NK cell-mediated ADCC to pfVM cells is also virtually cryopreserved pfVM and PSC from the same harvest as absent in human PBMC and is well in line with our fresh stimulator cells as target cells. These measures previous findings that only minimal amounts of pfVMwere made to limit differences in MHC make up bespecific antibody for facilitation of ADCC (i.e., IgG subtween pfVM and PSC, but also between stimulator cells type antibodies) are present in human serum (24). and target cells. Therefore, the differences we observed 
